UC San Diego Shiley Eye Institute UC San Diego Shiley Eye Institute UC San Diego Shiley Eye Institute
by name
Afshari, Natalie A. Brown, Stuart I. Camp, Andrew Chao, Daniel L. Ferrara, Napoleone Ferreyra, Henry A. Freeman, William R. Goldbaum, Michael H. Granet, David B. Haw, Weldon W. Heichel, Chris W. Kikkawa, Don O. Korn, Bobby S. Lee, Jeffrey E. Lin, Jonathan H. Nguyen, Thao P. Nudleman, Eric Robbins, Shira L. Savino, Peter J. Slight, Rigby Weinreb, Robert N. Welsbie, Derek S. Zhang, Kang
by specialty
Comprehensive Ophthalmology Cornea & Refractive Surgery Glaucoma Neuro-Ophthalmology Ophthalmic Genetics Ophthalmic Pathology Ophthalmic Plastic & Reconstructive Surgery Optometry & Low Vision Pediatric Ophthalmology & Eye Alignment Disorders Refractive Surgery / LASIK Retina & Vitreous Thyroid Eye Clinic
by condition
AMD (Age-related Macular Degeneration) Cataracts Corneal Conditions Cosmetic Surgery Diabetic Retinopathy Eye Movement Disorders Glaucoma Hereditary (Genetic) Disorders Low Vision Neuro-Ophthalmic Conditions Ophthalmic Plastic and Reconstructive Surgery Pediatric Conditions Refractive Errors Retinal Diseases Thyroid Eye Disease
Napoleone Ferrara, M.D.

Napoleone Ferrara, M.D.

Distinguished Professor of Ophthalmology and Pathology
Senior Deputy Director for Basic Sciences, UCSD Moores Cancer Center
Specialty Ophthalmic Pathology, Retina & Vitreous
Medical School University of Catania Medical School, Catania, Italy
Residency University of Catania Medical School, Catania, Italy
Fellowship University of California, San Francisco
Special Interest Regulation of angiogenesis (the formation of new blood vessels) and the role of VEGF (vascular endothelial growth factor); Continue to develop new therapies to treat age related macular degeneration building upon past development of AvastinĀ® and LucentisĀ®.
Publications View on PubMed

Napoleone Ferrara, M.D. earned his medical degree at the University of Catania Medical School in Italy and completed his postdoctoral research at University of California, San Francisco. Dr. Ferrara serves as a Distinguished Professor of Ophthalmology and Pathology in the UC San Diego School of Medicine as well as Senior Deputy Director for Basic Science at the UC San Diego Moores Cancer Center.

In February 2013, Dr. Ferrara was named one of 11 recipients of the inaugural Breakthrough Prize in Life Sciences. He was recognized for his work identifying the role of VEGF in promoting angiogenesis – the formation of new blood vessels that can feed tumor growth – and subsequent development of two major monoclonal antibody drugs: Bevacizumab (marketed as Avastin), which is used to treat multiple forms of cancer, including breast, brain and colorectal, and ranibizumab (marketed as Lucentis), which treats wet age-related macular degeneration, a leading cause of blindness.

Dr. Ferrara was elected to the National Academy of Sciences in 2006. He has also won numerous other awards, including the General Motors Cancer Research Award (2006), the ASCO Science of Oncology Award (2007), the Pezcoller Foundation/AACR International Award (2009), the Lasker~DeBakey Clinical Medical Research Award (2010), the Dr. Paul Janssen Award for Biomedical Research (2011), The Economist’s Innovation Award for bioscience, (2012) and the Gairdner Foundation International Award in 2014.

Faculty

Chairman

Whats Your Symptom Disclaimer

The information contained in this online site is intended to provide accurate and helpful health information for the general public. It is made available with the understanding that the author and publisher are not engaged in rendering medical, health, psychological, or any other kind of personal professional services on this site. The information should not be considered complete and does not cover all diseases, ailments, physical conditions or their treatment. It should not be used in place of a call or visit to a medical, health or other competent professional, who should be consulted before adopting any of the suggestions in this site or drawing inferences from it.

The information about drugs contained on this site is general in nature. It does not cover all possible uses, actions, precautions, side effects, or interactions of the medicines mentioned, nor is the information intended as medical advice for individual problems or for making an evaluation as to the risks and benefits of taking a particular drug.

The operator(s) of this site, and the publisher, specifically disclaim all responsibility for any liability, loss or risk, personal or otherwise, which is incurred as a consequence, directly or indirectly, of the use and application of any of the material on this site.

Click Here To Accept

Email Us

First Name*
Last Name*
Email*
Phone
MRN
Topic

Required *

Submit